Horizon Technology Finance Management

Onkos Surgical Inc. is a privately-held company based in Parsippany, New Jersey, focused on providing innovative technologies and solutions for surgical oncologists. Founded in 2014, the company specializes in addressing the challenges of musculoskeletal cancers and complex orthopedic conditions. Its offerings include GenVie, a magnesium bone scaffolding technology, and the ELEOS Proximal Tibia, a 3D-printed limb salvage replacement. Onkos Surgical emphasizes a personalized approach, utilizing advancements in virtual surgical planning, 3D modeling and printing, and implant design to enhance patient outcomes and experiences. By leveraging expertise in patient imaging analysis and workflow optimization, Onkos Surgical aims to simplify surgical processes and improve the effectiveness of tumor surgeries.

Ursa Space Systems Inc. is a geospatial services company that provides aerial and space-based data products to enhance geographic mapping and location-based information. Its offerings include imagery and information products that support market and weather forecasting, agricultural yield improvement, disaster response, and military intelligence. The company is known for its Ursa Global Oil Storage Monitoring solution, which provides insights into global oil storage for hedge funds, commodities traders, banks, and oil companies. Ursa Space Systems serves various sectors, including precision agriculture, business intelligence, weather monitoring, humanitarian relief, civil protection, mapping, and traffic applications. Founded in 2014, the company is headquartered in Ithaca, New York, and leverages radar satellite data to deliver timely reports, fostering transparency in global markets for the finance and energy industries.

GT Medical Technologies, Inc. is a medical device company dedicated to enhancing the treatment of brain tumors. Founded in 2017 and based in Tempe, Arizona, the company has developed GammaTile, an innovative device that integrates a conformable collagen matrix with brachytherapy seeds. This biocompatible technology aims to address the limitations of existing treatments for recurrent brain tumors. GammaTile has shown potential to transform care for approximately 176,000 patients annually in the United States. The product is protected by multiple patents in the U.S., Canada, and Europe, highlighting its unique design and therapeutic promise. Clinical trials conducted at the Barrow Neurological Institute have demonstrated notable clinical improvements in patients treated with GammaTile, positioning GT Medical Technologies as a significant player in the healthcare industry focused on brain tumor management.

Parse Biosciences is a biotechnology startup based in Seattle, Washington, that specializes in single-cell analysis. Founded in 2018 and rebranded from Split Biosciences in 2020, the company has developed innovative single-cell sequencing kit solutions that utilize combinatorial cDNA barcoding. This technology allows researchers to conduct experiments without the need for complex and costly microfluidic instruments. It also enables the fixation, freezing, and storage of samples, which separates sample extraction from downstream library preparation steps. As a result, researchers can analyze fixed samples collected on different dates in a single experiment, enhancing control over sample handling and minimizing errors. Additionally, Parse Biosciences’ technology improves gene detection in individual cells while reducing common confounding artifacts in single-cell sequencing, making it a valuable resource for researchers in the field.

Mirantis, Inc. specializes in providing software, services, training, and support for organizations seeking production-grade open source cloud solutions. The company offers a range of products, including OpenStack distribution software, Murano for managing cloud-ready applications, and a comprehensive cloud platform for container deployment. Mirantis enables businesses to create customized open source configurations for on-premise environments and provides tools for automating application deployment and scaling. The company also supports hybrid cloud architectures, helping connect various cloud infrastructures to optimize their use. In addition to its technology offerings, Mirantis provides managed services, implementation, migration, and training to enhance the capabilities of its clients. Founded in 1993 and headquartered in Campbell, California, Mirantis has established a global presence with offices in various countries, including Russia, France, Poland, and Ukraine.

Elligo Health Research, Inc. is a healthcare organization focused on enhancing clinical research through innovative infrastructure and technology. Founded in 2016 and headquartered in Austin, Texas, the company facilitates the integration of clinical research into healthcare clinics, enabling faster development of pharmaceutical, biotechnology, and medical device products. By utilizing advanced health informatics and electronic health records, Elligo helps identify suitable patients for clinical trials and offers physicians the necessary support to conduct trials efficiently without the need for significant infrastructure investments. This approach not only accelerates patient enrollment and trial completion for sponsors but also allows patients to participate in clinical research within their own healthcare settings, minimizing logistical challenges and contributing to advancements in medical care. Additionally, Elligo empowers physicians with knowledge of emerging therapies, ultimately enhancing patient care and engagement in the research process.

Tallac Therapeutics is a biopharmaceutical company based in Burlingame, California, focused on developing innovative immunotherapies for cancer patients. Established in 2018, the company specializes in creating conjugates of antibodies combined with potent toll-like receptor agonists. This approach aims to activate the immune system in a targeted manner, enhancing both innate and adaptive immunity to effectively combat various solid tumor malignancies. By providing advanced treatment options, Tallac Therapeutics seeks to improve patient outcomes in the fight against cancer.

Viken Detection Corporation, founded in 2013 and based in Newton, Massachusetts, specializes in the development and marketing of handheld X-ray instruments. The company offers a range of devices, including the Pb200i, a handheld XRF lead paint analyzer, which is utilized for lead-based paint testing, environmental assessments, metal alloy verification, and compliance testing for hazardous substances. In addition to its analytical tools, Viken Detection provides leasing and financing options for businesses of various sizes. The company's technology not only aids in material identification but also enhances security measures, assisting law enforcement and safety inspection agencies in detecting concealed threats and combating drug trafficking. Viken Detection was previously known as Heuresis Corporation before rebranding in February 2019.

SafelyYou is the artificial intelligence-enabled fall detection and prevention for dementia care.

Unagi Scooters is an electric scooter startup focused on providing an eco-friendly transportation solution for urban commuters. The company designs high-performance electric scooters that are capable of traveling long distances on a single charge and can navigate hilly terrains smoothly. By offering a convenient and efficient mode of transport, Unagi aims to alleviate common transportation challenges, such as high costs and carbon emissions, while enhancing the overall commuting experience.

Evelo Biosciences is a biotechnology company focused on discovering and developing oral biologics known as monoclonal microbials for the treatment of inflammatory diseases and cancer. These innovative medicines are designed to modulate systemic immunology through direct interactions with human cells in the gut, offering potential applications across a wide range of conditions, including autoimmune and neuroinflammatory diseases, as well as various cancers. Evelo's lead product, EDP1815, is currently undergoing clinical trials for psoriasis and atopic dermatitis, while other candidates are in preclinical stages for conditions such as psoriatic arthritis, asthma, and colorectal cancer. Founded in 2014 and based in Cambridge, Massachusetts, Evelo aims to enhance the efficiency and effectiveness of drug discovery by leveraging naturally occurring microbial entities with defined therapeutic effects.

Robin Healthcare, Inc. is a healthcare technology company that focuses on enhancing the medical industry through innovative software solutions. Founded in 2017 and headquartered in Berkeley, California, with an additional office in Austin, Texas, the company provides a range of services including clinical documentation solutions, medical scribe services, order and medication entry, chart review, billing and coding, and referral management. By integrating technology with trained medical scribes, Robin Healthcare aims to streamline administrative tasks and improve the doctor-patient experience, allowing healthcare professionals to dedicate more time to patient care while maintaining control over their practices.

Kodiak Robotics, Inc. is focused on developing autonomous technology specifically for long-haul trucking. Founded in 2018 and based in Mountain View, California, the company specializes in creating self-driving trucks designed to operate on highway routes. Kodiak Robotics employs advanced sensor fusion systems and innovative mapping solutions to enable its vehicles to manage all aspects of highway driving. This technology aims to enhance network efficiency and reduce operational costs for businesses in the logistics sector.

PDS Biotechnology Corporation is a biopharmaceutical company. It develops immunotherapies for cancer and other infectious diseases. It develops products to prevent and treat cervical, ovarian, melanoma, leukemia, pancreatic, oral, multiple myeloma, anal, vulvar, and penile cancers. The company offers PDS0101, a treatment for HPV-related cancers; PDS0102, a pandemic influenza vaccine; and PDS0103, a line of immunotherapy products for non-viral cancers. PDS Biotechnology Corporation was founded in 2005 and is headquartered in North Brunswick, New Jersey.

Nexii is a green construction technology company focused on creating sustainable and resilient buildings. The company designs and manufactures high-performance building solutions and green building products that promote health, affordability, and sustainability. By leveraging innovative construction methods, Nexii significantly reduces construction timelines and costs, making it easier for clients to adopt eco-friendly practices. The company's commitment to transforming the construction industry aims to address the challenges posed by climate change and enhance the overall quality of built environments.

Inbrace is a medical device company focused on innovative orthodontic solutions. Its flagship product, INBRACE, is a discreet alignment system that is placed behind the teeth, utilizing patented self-guiding technology to apply continuous forces for gentle correction of dental alignment. This approach significantly reduces pain and minimizes the number of required visits to the orthodontist, addressing common patient concerns and enhancing satisfaction. INBRACE is FDA registered and aims to expand access to orthodontic treatment, thereby driving practice growth for dental professionals. The company's platform incorporates digital treatment planning, computer modeling, and direct digital manufacturing, allowing for customized solutions that maintain high standards of care across various orthodontic cases.

Divergent Technologies, Inc. specializes in the development and manufacturing of 3D printed vehicles. Founded in 2014 and based in Los Angeles, California, the company has established a strategic partnership with PSA Group. Divergent has created the Divergent Adaptive Production System (DAPS™), an innovative software-hardware system that enables customers to design, additively manufacture, and automatically assemble complex structures for various applications, including automotive, aerospace, and defense. This system aims to enhance the efficiency and sustainability of the manufacturing process by optimizing designs, reducing material usage, and minimizing upfront capital expenditures. By eliminating traditional tooling requirements, Divergent seeks to drive innovation and sustainability within the vehicle manufacturing sector.

Soli Organic is an indoor farming startup specializing in the cultivation and distribution of fresh organic culinary herbs. The company supplies grocery stores with a year-round availability of various herbs, including basil, lime leaves, rosemary, chives, and arugula. By providing living organic plants with fresh-cut leaves, Soli Organic aims to enhance the flavor of meals while promoting healthy eating. Their commitment to regional growth allows consumers to enjoy locally sourced herbs throughout the year, contributing to a more flavorful and sustainable food experience.

Secure Transfusion Services is a life sciences company that aims to improve the quality and availability of transfusable blood components. The company is dedicated to helping the blood industry modernize and stabilize by enhancing the vital role that nonprofit blood banks play in ensuring the nation's blood supply.

Aerobiotix is a privately held company focused on developing and manufacturing proprietary environmental management devices. Its products are designed for use in institutional healthcare, home health, and commercial settings. The company provides a range of innovative technologies that effectively eliminate airborne viruses, bacteria, and spores, thereby enhancing indoor air quality and optimizing the overall environment.

Interior Define Inc. is a furniture design and manufacturing company founded in 2013 and based in Chicago, Illinois. It specializes in offering a range of customizable furniture products, including sofas, chairs, beds, and dining pieces. The company employs a made-to-order production approach, allowing customers to personalize their furniture in various aspects such as size, fabric, configuration, and leg style. This model minimizes inventory costs, enabling Interior Define to provide high-quality custom furniture at accessible prices. Customers can explore their options online through a 360-degree viewing experience and order free fabric swatches. Additionally, the company offers an augmented reality app to visualize furniture in their homes. Interior Define also operates Guideshop locations in several major cities, where customers can experience the products firsthand and receive personalized consultations from expert staff. The company is known for its customer-centric services, including complimentary white glove delivery and a standard 365-day return policy, enhancing the overall shopping experience.

IMV Inc. is a clinical-stage biopharmaceutical company based in Dartmouth, Canada, focused on developing innovative cancer immunotherapies and vaccines for infectious diseases. The company utilizes its patented DepoVax platform to enhance immune responses, allowing for controlled and prolonged exposure of antigens. Its lead candidate, DPX-Survivac, is a targeted T cell therapy that has shown promising results in multiple Phase 1 and 1b trials for late-stage ovarian cancer and relapsed/refractory diffuse large B cell lymphoma (DLBCL). IMV is currently conducting Phase 2 trials for DPX-Survivac across several cancer indications and exploring its use in combination with Merck's Keytruda. Additionally, IMV is developing a DPX-based vaccine candidate against COVID-19 and a vaccine targeting the respiratory syncytial virus. The company also has a diverse pipeline of vaccine candidates for various infectious diseases, including malaria and anthrax, and maintains partnerships in the animal health sector.

Everstream Analytics is a supply chain risk analytics company that delivers actionable insights to increase the resilience and agility of clients' supply chains, protecting revenue and reputation. It integrates with the clients' procurement, logistics, and business continuity platforms to deliver global, end-to-end visibility of supply chain risk. The company combines data science, proprietary intelligence, and multilingual specialists to monitor global risk and events in real-time to enable clients to act sooner. embeds risk analytics into decision making during planning and execution across all functions and phases of clients' supply chains.

Stealth BioTherapeutics is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of therapies targeting diseases linked to mitochondrial dysfunction. Founded in 2006 and based in George Town, Cayman Islands, the company is advancing its lead product candidate, Elamipretide, which aims to address both rare genetic and age-related mitochondrial diseases. Additionally, Stealth BioTherapeutics is developing SBT-20, a small peptide that stabilizes mitochondrial structure and function during oxidative stress, and SBT-272, a compound under evaluation for rare neurodegenerative diseases, including amyotrophic lateral sclerosis. Mitochondria play a crucial role in energy production and overall organ function, making the company's focus on these organelles significant in the biopharmaceutical landscape.

Nogin is an intelligent commerce platform that enables leading brands to keep pace with big retail, drive predictable profitability, and exponential growth, and grow rapidly into the future of commerce. Brands selling direct to consumers (D2C) and through online channel partners can use the Nogin Intelligent Commerce technology, a cloud-based e-commerce environment. Customers of Nogin are free to manage as much or as little of the infrastructure as they see fit while concentrating on their brands.

Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, dedicated to developing and commercializing implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company specializes in biomaterial design and bio-fabrication, focusing on collagen-based microfibers for tendon and ligament repair. Its innovative products are designed to meet the needs of warfighters, athletes, and individuals with sports injuries, utilizing a precision medicine approach to replicate the biological and biomechanical properties of native tissue. The goal of Embody is to enhance the quality of life for patients by restoring their pre-injury performance through effective healing solutions.

Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

RepTrak is the creator of an enterprise software platform and subscription-based service that helps businesses understand, improve, and protect their corporate reputation through key data analytics. Its proprietary RepTrak model is the global standard for measuring and analyzing global sentiment across industries and geographies, using proven data science models and machine learning techniques. The RepTrak Company, founded in 2004, owns a large reputation benchmarking database of over 1 million company ratings per year, which is used by CEOs, boards, and executives in over 60 countries worldwide.

LiquiGlide is a viable technology that allows viscous liquids to slide effortlessly. LiquiGlide is the first company to create permanently wet slippery surfaces. There is no other durable solution that makes viscous liquids slide easily.

Cerecor Inc. is a biopharmaceutical company dedicated to the development and commercialization of treatments for rare pediatric and orphan diseases. Founded in 2011 and headquartered in Rockville, Maryland, the company is advancing a clinical-stage pipeline that includes therapies for inherited metabolic disorders, such as CERC-801, CERC-802, and CERC-803, which are focused on congenital disorders of glycosylation. Additionally, Cerecor is developing CERC-006, an oral mTOR inhibitor aimed at treating complex lymphatic malformations, and two monoclonal antibodies: CERC-002, targeting the cytokine LIGHT for severe pediatric-onset Crohn's disease, and CERC-007, targeting IL-18 for autoimmune inflammatory diseases like adult onset Still's disease and multiple myeloma. Several of these therapies have received Orphan Drug Designation and Rare Pediatric Disease Designation, qualifying them for expedited review upon FDA approval. Cerecor also offers Millipred, an oral prednisolone for various inflammatory conditions.

Launched in 2016, Fingerlix is the brainchild of 4 foodies. Their purpose is to spread Joy through food by easing up cooking and exploration. They believe that Joy stems from spending more time with family and less time in the kitchen. Joy is maximum when they discover something new and different that entices their taste buds. Joy also comes from making healthier, happier food choices that leave us with a feeling of goodness. Through their Ready-to-Cook & Ready-to-Eat food options, they want to be a part of your cooking journey, partnering you, everyday - day after day. And they do their best to make that happen – sourcing choicest ingredients, maintaining extremely high hygiene standards and above all, inspiring your magical touch to transform every dish into ‘Your dish’.

Alula Holdings, LLC is a smart security company headquartered in Hudson, Wisconsin, that specializes in developing an integrated security platform for security dealers and installers. Founded in 2018, the company offers a comprehensive solution that encompasses security, alarm, video, and automation services tailored for renters, homeowners, and commercial installations. Alula's platform is designed to simplify security for independent dealers and their customers, providing low-cost, Internet-based interactive alarm systems and connected property products. By delivering differentiated security and automation solutions, Alula enables professional alarm dealers and integrators to enhance their business profitability while offering a consistent management experience. The company focuses on empowering its partners with technology-rich solutions that showcase their brand effectively.

IDbyDNA, Inc. is a company specializing in metagenomics technologies aimed at identifying infectious diseases. Founded in 2014 and based in Salt Lake City, Utah, it has developed a platform called Explify, which enables laboratories to detect and characterize pathogens using nucleic acid-based techniques. The company offers comprehensive testing services, including respiratory and research services, catering to hospitals, reference labs, clinical research institutions, and the biopharmaceutical sector. By leveraging computational biology and artificial intelligence, IDbyDNA strives to enhance diagnostic accuracy and treatment precision for infectious diseases, addressing the growing global challenge posed by these conditions.

Corinth MedTech, Inc. is a medical device company based in Cupertino, California, specializing in the manufacture of disposable bipolar transurethral and transcervical resectoscopes. Founded in 2011, the company has developed systems for endoscopically controlled tissue removal for male patients with benign prostatic hyperplasia (BPH) and for female patients with conditions such as abnormal uterine bleeding, fibroids, and polyps requiring hysteroscopic intervention. Corinth MedTech's proprietary technology enables medical professionals to perform precise resection and coagulation of prostate adenomas and bladder tumors, facilitating effective treatment under continuous flow conditions. The company aims to enhance patient outcomes through its innovative medical solutions.

Sonex Health, LLC, founded in 2014 and based in Rochester, Minnesota, specializes in developing micro-invasive surgical devices aimed at enhancing patient care and reducing healthcare costs. The company is known for its SX-One MicroKnife featuring Meerkat Technology, which enables a novel approach to treating carpal tunnel syndrome through an ultrasound-guided carpal tunnel release procedure. This innovative technique allows surgeries to be performed in outpatient settings rather than operating rooms, facilitating quicker patient recovery and improved cosmetic outcomes. The SX-One MicroKnife utilizes a micro-incision significantly smaller than traditional methods, often requiring only a small adhesive bandage for closure. This results in a low-trauma surgical experience that allows patients to begin rehabilitation immediately, minimizing downtime and promoting a swift return to daily activities. Sonex Health is dedicated to refining surgical practices to address important healthcare challenges effectively.

Getaround, Inc. is an online marketplace that facilitates peer-to-peer car sharing and local car rentals, allowing users to rent cars by the hour or day through its app. Founded in 2009 and based in San Francisco, California, the company operates in several cities across the United States, including San Francisco, San Diego, Chicago, and Washington, D.C. Getaround’s platform utilizes patented technology to provide a contactless experience, eliminating the need for traditional rental procedures such as waiting in line or meeting car owners. Users can choose from a variety of vehicles, including luxury cars and trucks, while benefiting from included insurance and 24/7 roadside assistance. This model not only offers convenience but also helps car owners earn extra income, thereby reducing the cost of car ownership and promoting environmental sustainability.

Topia Limited is a provider of mobility management solutions that focuses on global talent mobility for businesses. Established in 2010 and headquartered in London, with an additional office in San Francisco, Topia offers a comprehensive platform that streamlines the entire talent mobility process. This includes relocation and expatriate administration, tax and immigration management, and payroll calculations. The company’s platform, known as Topia One, is a cloud-based system that integrates data standards across global talent mobility. Additionally, the Topia Go mobile application allows employees to manage their relocations and assignments effectively. Topia serves a diverse clientele, including well-known brands such as Dell, Schneider Electric, and Deliveroo, and has established strategic partnerships with organizations like Fragomen Worldwide and the Employee Mobility Institute. The company was previously known as MOVE Guides Limited until its rebranding in April 2018.

Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.

Magnolia Medical Technologies, Inc. is a Seattle-based company that specializes in developing medical devices aimed at enhancing the accuracy of diagnostic blood culture tests. The company's flagship product, SteriPath, is a vacuum-assisted blood collection system designed to eliminate contamination from initial blood samples, thereby reducing false-positive results that can lead to misdiagnosis of conditions like sepsis. This innovative system employs a pre-assembled and sterile collection method that actively diverts potentially contaminated blood, allowing for the collection of uncontaminated samples through a separate pathway. By improving the quality of diagnostic specimens, Magnolia Medical Technologies seeks to enhance patient outcomes, lower hospital costs, and address the growing issue of antibiotic resistance. The company, incorporated in 2011, also holds a substantial intellectual property portfolio, which includes over 70 issued patents and more than 50 additional patent applications pending.

Ceribell, Inc. is a medical technology company that designs and manufactures devices for electroencephalography (EEG) data acquisition and interpretation, aimed at improving the diagnosis and management of neurological conditions. Its flagship product, the Ceribell EEG System, includes a flexible EEG Headband that accommodates various hair types and head sizes, alongside a portable EEG Recorder that ensures clinical-quality data and on-device display. The system is designed to be set up by any healthcare provider within six minutes, making EEG testing more accessible and efficient. Notably, it features a unique function that converts brainwaves into sound, allowing for quicker detection of seizures without the need for specialized technicians. This innovation facilitates earlier diagnosis and targeted treatment for patients, particularly for non-convulsive seizures, thereby reducing the risk of complications and improving overall patient outcomes. Established in 2014 and based in Mountain View, California, Ceribell is committed to enhancing care in hospital ICUs, inpatient units, and emergency departments.

Castle Creek Biosciences is focused on developing and commercializing novel, personalized gene therapies for rare skin and connective tissue disorders with high unmet need. It was founded in 2015 and headquartered in Pennsylvania, United States.

OutboundEngine, Inc. is a marketing technology company based in Austin, Texas, that specializes in marketing automation software for small and midsize businesses. Founded in 2010, the company offers a cloud-based platform that streamlines various marketing tasks, including automated email marketing, social media posting, and online review collection. Its flagship product, The OutboundEngine Platform, is designed to deliver tailored marketing programs, while its Harmony platform focuses on unifying marketing efforts across franchise and agent networks. OutboundEngine serves a diverse range of industries, including real estate, finance, insurance, and automotive, helping over 10,000 customers enhance their online marketing efforts. The company has gained recognition for its innovative solutions and has been acknowledged as a top workplace in Austin.

Meditrina, Inc. is a medical device company based in San Jose, California, specializing in tissue removal solutions for intrauterine pathology. Founded in 2016, the company has developed the Aveta System, an all-in-one solution designed for hysteroscopic diagnostic and therapeutic procedures. This system enables healthcare professionals to perform tasks such as the removal of polyps and fibroids in both office and operating room settings. The Aveta System features wide-angle HD hysteroscopy with electronic image-lock, advanced fluid management for better pressure and fluid control, and a compact design that allows for seamless integration into various medical environments. By providing advanced, convenient, and cost-effective options, Meditrina aims to enhance the care experience for both patients and physicians.

Encore Dermatology is a privately held dermatology company headquartered in Malvern, Pennsylvania, established in 2015. The company specializes in providing prescription therapies and medical devices specifically designed for dermatologists. Its product offerings encompass a variety of medical dermatology solutions aimed at treating several topical conditions, including acne and atopic dermatitis. By focusing on these areas, Encore Dermatology aims to enhance patient access to effective skincare treatments and improve overall patient outcomes in dermatological care.

Mustang Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative cell and gene therapies aimed at treating hematologic cancers, solid tumors, and rare genetic diseases. The company has a diverse pipeline that includes gene therapy programs for rare genetic disorders and various chimeric antigen receptor (CAR) T cell therapies targeting both hematologic malignancies and solid tumors. Notable projects include MB-107, a gene therapy aimed at treating X-linked severe combined immunodeficiency, which is currently undergoing Phase 1/2 clinical trials. Other therapies under development include MB-102 for acute myeloid leukemia, MB-106 for B-cell lymphomas, and multiple CAR T programs targeting glioblastoma, prostate cancer, and pancreatic cancer. Mustang Bio also collaborates with institutions such as Nationwide Children’s Hospital and Beth Israel Deaconess Medical Center for research and development in gene editing and oncolytic viruses. Established in 2015 and headquartered in New York, Mustang Bio operates as a subsidiary of Fortress Biotech, Inc.

CSA Medical, Inc. specializes in the development and manufacturing of spray cryotherapy medical devices. The company's flagship product, the truFreeze device, utilizes cold liquid nitrogen as a cryosurgical tool for the destruction of unwanted tissue in dermatology, gynecology, and general surgery, while facilitating the regrowth of healthy tissue. Additionally, CSA Medical offers the Rapid AV Spray Kit, which enhances the truFreeze system by reducing the time required for liquid nitrogen application. Originally founded as Crymed Technologies in 1993, the company rebranded to CSA Medical in April 2006. Headquartered in Lutherville Timonium, Maryland, CSA Medical also operates a research and development facility in Lexington, Massachusetts.

MacuLogix focuses on detecting and tracking age-related macular degeneration. It leverages the science of dark adaptation to help eliminate preventable blindness caused by AMD. Through its AdaptDx® dark adaptometer, MacuLogix enables eye care professionals to detect, monitor, and start treating AMD three years before it can be seen in order to prevent vision loss.

New Signature delivers an amazing customer experience to customers across all company sizes, geographies and industries and helps them solve business challenges using Microsoft solutions. Our process driven approach is specifically designed to consistently deliver success to customers that need support for complex projects that require substantial creativity, strategic vision and stellar technology expertise. We help our customers make major investment decisions through rigorous economic analysis that presents the value of Microsoft solutions. We then provide hands-on IT expertise to plan, design, deploy, customize and extend, manage and support their Microsoft solutions. New Signature ensures a maximum ROI by delivering customized user adoption and learning solutions for business users and IT professionals.

Ontrak is a behavioral health company that utilizes artificial intelligence and technology to provide specialized health management services to health plans, employers, and unions through a network of licensed healthcare providers. The company's Ontrak program addresses substance dependence as a chronic disease, aiming to improve member health and reduce costs through integrated medical and psychosocial interventions, long-term care coaching, and online recovery tools. Additionally, Ontrak's platform employs claim-based analytics and predictive modeling to deliver personalized care, focusing on treating behavioral conditions that contribute to chronic medical issues like diabetes, hypertension, and heart disease. Through these integrated solutions, Ontrak seeks to enhance health outcomes and improve the overall well-being of its members.

Since 2003, we help companies driving digital innovation, with disruptive methodologies. We design new brands, new services and new products, in collaboration with our clients and their partners. We assist large groups, start-ups and SMEs in the conduct of disruption (Disrupt), of digital experience design (Design), and the conduct of growth (Scale). Our approach is different from a digital agency: we are structured as a consultancy, with concrete execution abilities in design and in marketing.

Audacy is a space communications service provider enabling continuous satellite and launch vehicle connectivity from the launchpad to the Moon. Its mission is to deliver anytime, highly operable connectivity that advances humankind to an unparalleled age of space exploration and discovery. The company was founded in 2015 and headquartered in Mountain View, California.

IntelePeer is a communications automation platform that utilizes generative AI to enhance customer interactions for businesses. By offering a cloud-based Communications Platform as a Service (CPaaS), the company provides on-demand IP communications and SIP trunking services tailored for enterprises. IntelePeer's platform integrates seamlessly with existing systems, allowing businesses to streamline their communication processes across multiple channels. Its focus on automation not only reduces operational costs but also improves customer experience by delivering efficient and effective communication solutions. The incorporation of AI and analytics further enhances the platform's capabilities, enabling clients to achieve higher levels of customer satisfaction and engagement.

Conventus Orthopaedics provides a range of orthopedic and sports medicine services. The physicians specialize in orthopedic surgery, reconstructive surgery, spine surgery, joint replacement, sports medicine, physical therapy, and operative care of fractures, arthritis, strains, sprains, and sports-related injuries. Conventus was formed by a team of medical professionals with the sole purpose of creating less invasive ways to treat challenging periarticular fractures. By leveraging advanced nitinol technology, the Conventus team has developed a platform technology that provides robust fixation and creates reliable repairs. The company was incorporated in 2009 and is based in Maple Grove, Minnesota.

Aerin Medical Inc. is a health technology company based in Sunnyvale, California, specializing in non-invasive treatment solutions for nasal breathing disorders. Established in 2011, the company has developed therapeutic devices that utilize low-power radiofrequency energy to remodel nasal soft tissues, effectively addressing the underlying causes of nasal congestion. Its primary products include the VivAer procedure for nasal airway obstruction and the RhinAer procedure for chronic rhinitis, both of which employ proprietary temperature-controlled technology. These solutions offer ENT physicians appealing alternatives to invasive surgery, allowing them to treat patients under local anesthesia with minimal to no downtime. Aerin Medical aims to meet the unmet needs of individuals suffering from chronic nasal airway conditions through its innovative and office-friendly product offerings.

Titan Pharmaceuticals, Inc. is a biopharmaceutical Company developing proprietary therapeutics primarily for the treatment of serious medical disorders. Titan’s principal asset is Probuphine®, the first slow-release implant formulation of buprenorphine hydrochloride (“buprenorphine”), designed to maintain a stable, round-the-clock blood level of the medicine in patients for up to six months following a single treatment. The outpatient treatment of opioid dependence with daily dosed sublingual buprenorphine formulations represents a $1.3 billion market in the U.S., and a seven day transdermal patch formulation of buprenorphine for the treatment of chronic pain was launched in the U.S. in 2011. This novel implant formulation is inserted subdermally in a patient’s upper arm providing continuous medication, and has the potential to enhance patient compliance to treatment, and limit diversion for illicit use and accidental exposure to the sublingual formulations. The New Drug Application (NDA) was submitted to the FDA in October, 2012 seeking approval for treatment of opioid dependence. In December 2012, Titan entered into a license agreement with Braeburn Pharmaceuticals Sprl (“Braeburn”) that grants Braeburn exclusive commercialization rights to Probuphine® in the United States and Canada. Titan received a non-refundable up-front license fee of $15.75 million and will receive a $50 million milestone payment upon the approval of the NDA by the FDA. Additionally, Titan will be eligible to receive up to $130 million upon achievement of specified sales milestones and up to $35 million in regulatory milestones in the event of future NDA submissions and approvals for additional indications, including chronic pain. Titan will receive tiered royalties on net sales of Probuphine ranging from the mid-teens to the low twenties. Probuphine is the first product to utilize ProNeura™, a novel, proprietary, long-term drug delivery technology. The ProNeura technology has the potential to be used in developing products for the treatment of other chronic conditions, such as Parkinson’s disease, where maintaining stable, round-the-clock blood levels of a drug can benefit the patient and improve medical outcomes. Finally, Titan is also entitled to royalty revenue of 8-10% of net sales of Fanapt® (iloperidone), an atypical antipsychotic compound being marketed in the U.S. for the treatment of schizophrenia by Novartis Pharma AG (“Novartis”) under a sub-license agreement based on a licensed U.S. patent that expires in October 2016 (does not include a possible six month pediatric extension). Substantially all of this future royalty revenue has been sold to Deerfield Management (“Deerfield”), a healthcare investment fund, in exchange for cash and debt considerations which have been used to advance the development of Probuphine and for general corporate purposes.

PebblePost is the leading digital-to-direct mail marketing platform. They capture online interest and intent data to send relevant direct mail that activates buying decisions at home and drives conversions everywhere. The company invented Programmatic Direct Mail to help brands convert more shoppers into buyers using advanced targeting, algorithmic optimization, attribution, and quantitative analysis. PebblePost is a venture-backed company based in New York.

IgnitionOne, Inc. is a New York-based company that specializes in cloud-based digital marketing software solutions for online marketers globally. Founded in 2004, it offers a comprehensive customer intelligence platform designed to help enterprise marketers identify and engage valuable customers across various channels. The platform provides tools for data management, marketing analytics, and omnichannel targeting, allowing users to consolidate customer information and optimize marketing efforts effectively. Key offerings include a Marketing Hub for data management, a Digital Marketing Dashboard for insights, and solutions for creative asset management and search management. IgnitionOne also focuses on website personalization and email optimization to enhance marketing strategies. Formerly known as SearchIgnite, Inc., the company rebranded in 2011 and has since established itself as a significant player in the marketing technology sector.

Strongbridge Biopharma plc is a commercial-stage biopharmaceutical company dedicated to developing and commercializing therapies for rare diseases with significant unmet medical needs. The company markets Keveyis, an oral carbonic anhydrase inhibitor used to treat various forms of primary periodic paralysis in the United States. Its clinical pipeline includes Recorlev, a cortisol synthesis inhibitor currently in Phase III trials for endogenous Cushing's syndrome, and Veldoreotide, a somatostatin analog that has completed Phase II trials for acromegaly. Founded in 1996 and based in Trevose, Pennsylvania, Strongbridge Biopharma aims to build its portfolio around rare endocrine disorders and plans to utilize a focused sales strategy to reach its target markets. The company is also actively seeking to in-license or acquire complementary products to enhance its rare disease franchise.

Receptiv is a mobile video advertising platform that enhances ad performance by connecting brands with receptive users during significant moments. Founded in 2011 as MediaBrix, the company rebranded to Receptiv in March 2017 and is headquartered in New York City. It offers solutions through both programmatic and managed services, focusing on creating contextual brand engagements. Receptiv utilizes its first-party data management platform, Motiv, which leverages insights from 150 million device IDs to combine emotional targeting with audience intelligence. The platform operates across more than 1,300 premium apps, generating 500 million key advertising moments monthly. Receptiv's client roster includes major brands such as Mars, Coca-Cola, and Microsoft. As of May 2018, it functions as a subsidiary of Verve Wireless, Inc., and is recognized for its innovative approach in the digital advertising space.

ScoreBig.com is a leading destination for savings on Sports, Music and Theater tickets. At ScoreBig.com, consumers save up to 60% on tickets for Pro and College Sports, Music, Theater and Family events. ScoreBig.com has tickets to thousands of games and performances, from the rafters to the front row. ScoreBig.com is the first and only opaque sales channel available for the $20 billion live event industry. ScoreBig.com enables pro and college sports teams, and arts, music and theater organizations to move unsold tickets without the cannibalization risks inherent in traditional discounting. ScoreBig.com’s founders, investors and key executives have backgrounds in the NBA, NFL, Theater and Arts and leading ticketing, media and e-commerce companies. Founded in 2009, ScoreBig’s offices are located in Hollywood, California. ScoreBig.com was recently ranked No. 44 overall and No. 7 in Los Angeles on Deloitte’s Technology Fast 500.

Avalanche Technology, Inc. is a technology company based in Fremont, California, specializing in the development and marketing of non-volatile spin transfer torque magnetic random access memory (MRAM) devices. Founded in 2006, the company provides innovative memory solutions aimed at enhancing speed, endurance, and energy efficiency across a range of applications, including mobile devices, the Internet of Things, enterprise storage, computing, networking, telecommunications, and automotive industries. Avalanche Technology's products serve as alternatives to traditional static random access memory, flash, and read-only memory, utilizing perpendicular magnetic tunnel junction technology to deliver low power consumption. With a strong focus on research and development, the company holds a substantial portfolio of over 200 patents related to its cell, circuit, process, and system innovations, positioning itself as a leader in the evolving landscape of memory technology.

Nomi is an omni-channel marketing platform that assists retailers in enhancing customer engagement and optimizing the return on investment from their marketing and store operations. It effectively analyzes and measures the impact of various marketing initiatives by quantifying visitor traffic generated by campaigns and calculating the lifetime value of newly acquired customers. The platform evaluates store performance by determining how well retailers convert potential customers into actual buyers, identifies underperforming staff, and assesses the impact of training and management investments on customer behavior. Additionally, Nomi provides a comprehensive view of the customer conversion funnel, enabling retailers to anticipate the health of their stores and address operational issues before they affect profitability. Founded in September 2012 and based in New York, Nomi was established by Marc Ferrentino, Corey Capasso, Wesley Barrow, Peter Quintas, and Robert Balousek.

New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company focused on developing proprietary prescription medications that leverage currently marketed drugs and generally recognized as safe (GRAS) active pharmaceutical ingredients for therapeutic applications with substantial market potential. The company is advancing a product pipeline that features innovative, oral, controlled-release technologies, enhancing dosing accuracy, safety, efficacy, and patient convenience. NHP's research is supported by intellectual property licensed from Yale University, allowing for the development of new therapeutic indications using established compounds.

Bridge2 Solutions, Inc. operates a marketing solutions platform that facilitates engagement and loyalty for financial institutions, retailers, and Fortune 500 companies. Founded in 2006 and headquartered in Alpharetta, Georgia, with additional locations in Scottsdale, Arizona, and Chennai, India, the company connects consumers with retail partners and loyalty programs through various offerings, including merchandise, travel, and entertainment. Its cloud-based platform provides software-based redemption services, allowing loyalty and rewards program sponsors to seamlessly interact with trusted retail and travel brands without the need for physical inventory. In addition to its core services, Bridge2 Solutions offers comprehensive customer and account support, as well as managed services such as database management and network monitoring, ensuring efficient operations for its clients.

Medsphere Systems Corporation provides open source software for the healthcare industry. It offers OpenVista, a portfolio of products and professional services for hospitals, clinics, and integrated delivery networks. The company's OpenVista includes OpenVista Enterprise, an electronic health record solution that offers patient and health information management system, clinical information system, laboratory, pharmacy, radiology, nutrition and food service, and interface suite modules. In addition, the company offers implementation, training, support, and development services. Medsphere Systems Corporation was founded in 2002 and is headquartered in Carlsbad, California.

SilkRoad Technology, Inc. provides cloud-based talent management solutions for organizations in the United States and internationally. Founded in 2003 and headquartered in Chicago, Illinois, the company offers a comprehensive suite of tools designed to enhance various aspects of human resources. Key offerings include SilkRoad Suite Start for talent acquisition, SilkRoad Recruiting for utilizing social channels in hiring, and SilkRoad Onboarding for employee integration. Additionally, it provides SilkRoad Performance for managing employee performance, SilkRoad Learning for social learning and content management, and SilkRoad HRMS for maintaining accurate employee records. The company serves diverse sectors such as financial services, healthcare, higher education, manufacturing, professional services, and retail. SilkRoad Technology also offers pre-sales consultation, implementation support, and training services to ensure clients effectively leverage their HR solutions. With locations across North America, Europe, Asia, and Australia, SilkRoad Technology focuses on delivering personalized experiences that enhance employee engagement and contribute to improved business outcomes.

SavingStar, Inc. is an online grocery rewards platform that offers cash back on grocery and online shopping purchases. Founded in 2010 and based in Waltham, Massachusetts, the company allows users to redeem offers by linking them to their supermarket and drugstore loyalty cards or by submitting a receipt image. Shoppers earn cash back on specific item-level purchases, with the value automatically credited to their SavingStar or partner accounts. The platform also supports double cash back at various online retailers, including popular websites. Additionally, brands can utilize the platform to run promotions, incentivizing shoppers to buy specific products or engage with content. SavingStar was formerly known as SaveWave Inc. and adopted its current name in February 2011. It operates as a subsidiary of Quotient Technology Inc.

ScoreBig.com is a leading destination for savings on Sports, Music and Theater tickets. At ScoreBig.com, consumers save up to 60% on tickets for Pro and College Sports, Music, Theater and Family events. ScoreBig.com has tickets to thousands of games and performances, from the rafters to the front row. ScoreBig.com is the first and only opaque sales channel available for the $20 billion live event industry. ScoreBig.com enables pro and college sports teams, and arts, music and theater organizations to move unsold tickets without the cannibalization risks inherent in traditional discounting. ScoreBig.com’s founders, investors and key executives have backgrounds in the NBA, NFL, Theater and Arts and leading ticketing, media and e-commerce companies. Founded in 2009, ScoreBig’s offices are located in Hollywood, California. ScoreBig.com was recently ranked No. 44 overall and No. 7 in Los Angeles on Deloitte’s Technology Fast 500.

NinePoint Medical, Inc. is a transformational medical device company developing innovative, real-time, in vivo pathology devices. The company's first goal is to develop a device that enables remote pathology, or telepathology, which would facilitate immediate review of images during diagnostic procedures. This capability could potentially provide physicians with immediately actionable information and eventually allow them to pursue therapeutic remedies at the time of diagnosis. This convergence of access, diagnosis and treatment during one procedure is expected to improve patient experiences and outcomes, improve the efficiency of care and provide important savings to the healthcare system. Headquartered in Cambridge, Mass., NinePoint is backed by Third Rock Ventures and Prospect Venture Partners.

Palatin Technologies is a biopharmaceutical company focused on developing targeted, receptor-specific peptide therapeutics to address significant unmet medical needs. Based in Cranbury, New Jersey, the company’s lead product is Vyleesi, a melanocortin receptor agonist designed for the treatment of premenopausal women with hypoactive sexual desire disorder. Palatin is also advancing several other candidates, including oral PL8177, which targets inflammatory bowel diseases, and systemic PL8177, aimed at treating non-infectious uveitis and COVID-19. Additionally, the company is developing PL9643 for anti-inflammatory ocular conditions like dry eye disease, as well as PL3994 and PL5028, which target cardiovascular and fibrotic diseases. Their research emphasizes the modulation of melanocortin and natriuretic peptide receptor systems to resolve inflammation and facilitate tissue healing, with applications extending to various conditions, including obesity, erectile dysfunction, and pulmonary diseases.

Interleukin Genetics, Inc. is a genetics-focused personalized health company that develops genetic tests for sale to the emerging personalized health market. Their vision is to build a leading personalized health and wellness company. They believe that the science of applied genetics can empower individuals to personalize their health and provide valuable information to assist in drug development. They currently have two primary focus areas to their business. The first is personalized health, which is primarily focused on providing genetic test products to customers. These products are distributed via sales partners and their own sales channels, with the goal of providing guidance for the individual interested in improving their health and wellness. The second is a research and development effort focused on developing genetic tests linked to a partner’s products for marketing and sales into medical and dental channels. Both areas contribute toward their overall mission of providing products that can help individuals improve and maintain their health through preventive measures.

ZetrOZ, LLC specializes in the development and manufacturing of advanced ultrasound systems aimed at therapeutic and diagnostic applications. The company offers a range of products, including UltrOZ Elite therapeutic systems designed for both human and veterinary use, as well as high-intensity focused ultrasound systems applicable in biomedical research and industrial processes. ZetrOZ also provides various ultrasound transducers suited for therapeutic uses such as physiotherapy, drug delivery, and wound care, alongside applications in industrial monitoring and aquatic deterrents. The company has introduced innovative generator technology, enhancing the efficiency and portability of ultrasound systems, making them more economically viable. Founded in 2009 and based in Trumbull, Connecticut, ZetrOZ focuses on non-invasive medical devices that aim to alleviate chronic musculoskeletal pain through advanced treatment monitoring and user-friendly design features.

IntegenX, Inc. specializes in developing human DNA identification solutions, particularly for forensics and law enforcement. The company utilizes advanced technology platforms that combine fluidics, optics, and biochemistry to create automated sample-to-answer products for DNA-based identity testing. Among its offerings are the RapidHIT System, which automates the production of standardized DNA profiles from various human samples, and the RapidHIT GlobalFiler Express Kit, designed for direct processing of crime scene samples. Additionally, IntegenX provides systems like the Apollo 100 and Apollo 200 for DNA sequencing and sample preparation. Founded in 2003 and based in Pleasanton, California, IntegenX was previously known as Microchip Biotechnologies, Inc. and became a subsidiary of Thermo Fisher Scientific Inc. in 2018. The company's products are distributed internationally across various countries, enhancing their reach in the market for reliable DNA identification solutions.

SpringCM is a secure document and contract management platform used to solve critical business needs. SpringCM delivers affordable, easy-to-deploy document management and workflow solutions in a completely Web-based environment. SpringCM's award-winning ECM service eliminates software installations, hardware maintenance, and prolonged customization cycles associated with on-premises applications.

Founded in 1999, Mblox is a leading provider of mobile messaging and payment solutions, specializing in Application-to-Person communication. The company has established over 100 direct relationships with mobile carriers worldwide, making it a trusted partner for businesses needing reliable mobile messaging services. Mblox processes approximately 7 billion messages annually for over 4,000 clients, ranging from small startups to large multinational corporations. Their cloud-based platform is designed to meet the diverse needs of various industries, including financial services, government, transportation, logistics, retail, and advertising. Mblox is committed to customer service, offering 24/7 email support through an in-house team of experts, along with tailored support packages to accommodate different business requirements.

GenePeeks is a genetic information company with a mission to help families protect the health of future generations. Our patented technology previews a future child’s genetic profile, identifying disease risk impossible to observe with existing pre-conception screening tools. The company’s software digitally weaves together Next-Gen sequencing data from two prospective parents, simulating genetic recombination and reduction that occurs naturally in human reproduction. The process generates analytic targets that include tens of thousands of “virtual genomes.”

Social Intelligence Corp. specializes in providing social media data and analytics to commercial and government organizations. Based in Santa Barbara, California, the company offers software-as-a-service tools that include predictive scoring algorithms and extensive data resources. Their products are designed for employment background screenings, insurance claims investigations, corporate due diligence, and various government services. Social Intelligence is committed to adhering to the Fair Credit Reporting Act and complies with federal and state regulations to ensure responsible use of publicly available online information. The company emphasizes the importance of privacy, productivity, and community involvement, and is supported by a diverse team with extensive experience in software, insurance, government services, and employment sectors.

AccuVein Inc. is a manufacturer of vein visualization solutions aimed at enhancing clinical care for healthcare professionals. Founded in 2006 and based in Medford, New York, the company specializes in portable, non-contact devices that enable practitioners to visualize peripheral veins on a patient's skin. Its flagship product, the AV400, utilizes proprietary technology to assist in locating veins for various medical procedures, including IV access, blood draws, and cosmetic injections. AccuVein also offers a range of products, including hands-free and wheeled solutions, to cater to different medical settings such as surgery centers, imaging centers, and long-term care facilities. The company's products are distributed through a network of sales representatives and distributors both domestically and internationally.

Mederi Therapeutics manufactures and markets innovative medical devices that deliver radiofrequency energy to treat disease states affecting the human digestive system. All Mederi therapies are outpatient, minimally invasive, and promote rapid recovery. Mederi Therapeutics is located in Greenwich, Connecticut.

Inotek Pharmaceuticals is developing molecules with novel mechanisms of action to fulfill major unmet medical needs in significant diseases of the eye. Complete loss of vision or vision impairment currently affects 3.3 million people over the age of 40 in the United States, with the most common diseases including age-related macular degeneration (AMD), glaucoma, cataract and diabetic retinopathy. With the continued aging of the population, the National Eye Institute projects that this number will grow to 5.5 million people by the year 2020.

Overture Networks develops and manufactures high-speed carrier ethernet edge and aggregation solutions. Its products combine packet-switched and circuit-switched areas into a single architecture-at cost points to offer carrier Ethernet services to any size location over copper, fiber, or optical transport.

Valore specializes in enhancing the textbook industry by addressing its inefficiencies, thereby making textbooks and course materials more affordable and accessible for students, bookstores, professors, and educational institutions. Based in San Diego, ValoreBooks.com serves as a major marketplace for college students to buy and sell textbooks at significantly lower prices than traditional campus bookstores. With access to a vast selection of titles from over 14,000 booksellers nationwide, students can find textbooks at discounts of up to 90 percent off the list price. Valore is recognized for its commitment to affordability and superior customer service, contributing positively to the educational experience.

Radisphere is the leading provider of standards-based radiology delivery solutions for health systems, with more than 100 clients in 28 states. We use cloud-based workflow management technology with advanced routing logic and 24/7 care management services to connect the hospitals and radiology groups across a system. By centralizing the management of radiology, Radisphere enables systems to leverage their own scale to deliver higher quality and lower cost care. Our clients can also standardize on our industry leading teleradiology services to enable final reads around-the-clock and scalable subspecialty coverage. Radisphere is transforming the practice of radiology at health systems by establishing measurable performance standards and accountability for diagnostic accuracy, appropriate utilization, service level excellence and patient care.

Enphase Energy, Inc. is a global energy technology company specializing in home energy solutions for the solar photovoltaic industry. Founded in 2006 and headquartered in Fremont, California, the company designs, develops, manufactures, and sells innovative products including semiconductor-based microinverters that convert energy at the individual solar module level. Enphase combines these microinverters with proprietary networking and software technologies to offer energy monitoring and control services. The company's portfolio also includes AC battery storage systems, communication gateways, and cloud-based monitoring services. Enphase sells its solutions to a range of customers, including solar distributors, large installers, original equipment manufacturers, strategic partners, and directly to homeowners. Additionally, Enphase provides training resources for solar and storage installers through Enphase University. The company focuses on improving the performance and reliability of solar energy systems, aiming to simplify solar power usage and facilitate a transition to renewable energy.

Grab Media is a prominent video distribution company that specializes in connecting premium video content with a diverse array of professional sources and well-known advertisers. The company offers digital advertising and video syndication solutions, enabling marketers to effectively reach large, engaged audiences. By hosting, distributing, and monetizing streaming media, Grab Media allows brands to concentrate on promoting their messages while ensuring that their content reaches the right viewers.

Tagged.com was launched in 2004, and is an explosively growing social-networking portal developed specifically for teens aged 13 through 19. Emerging as the premier brand in the lucrative teen demographic, Tagged.com is rapidly becoming the number one teen site on the web.

Revance Therapeutics is a biotechnology company that focuses on developing, manufacturing, and commercializing neuromodulators for aesthetic and therapeutic applications. Its primary product, DaxibotulinumtoxinA for injection (DAXI), is undergoing various clinical trials for treating conditions such as glabellar lines, cervical dystonia, adult upper limb spasticity, and plantar fasciitis, while also being explored for chronic migraine treatment. Additionally, Revance is developing topical formulations of DAXI and a biosimilar to BOTOX. The company has established collaborations for the development and commercialization of these products. Revance also offers a portfolio of aesthetic products, including the RHA Collection of dermal fillers and the HintMD platform. Founded in 1999 and headquartered in Newark, California, Revance Therapeutics was previously known as Essentia Biosystems.

Copan Systems, Inc. specializes in providing storage solutions that utilize idle disk technology to manage long-term persistent data. Founded in 2002 and based in Longmont, Colorado, the company offers a range of products, including virtual tape libraries designed for backup and disaster recovery, as well as archiving solutions that enable file-level storage and retrieval of digital assets. Its offerings encompass data protection, tiered storage, and cooling solutions, catering to various industries such as education, finance, government, healthcare, technology, media, and service providers.

Intarcia Therapeutics, Inc. is a biopharmaceutical company focused on developing therapies for chronic conditions that require long-term management. The company is known for its innovative Medici Drug Delivery System, which facilitates subcutaneous delivery of therapies for diseases such as type 2 diabetes, obesity, and autoimmune disorders. Its lead product, ITCA 650, is currently in phase 3 clinical trials designed to provide sustained treatment for diabetes through a steady-state dosing system. Additionally, Intarcia's DUROS platform stabilizes and delivers therapeutic proteins and peptides, including devices aimed at treating conditions such as Hepatitis C. Founded in 1997 and originally named BioMedicines, the company rebranded to Intarcia Therapeutics in 2004. It is headquartered in Boston, Massachusetts, with a manufacturing facility in Hayward, California, and a research and development center in Durham, North Carolina.